Author Of 1 Presentation
INCREASING MAGNESIUM SULFATE ADMINISTRATION RATES IN WOMEN WITH THREATENED PRETERM LABOUR - A QUALITY IMPROVEMENT INITIATIVE
Abstract
Background
Current UK incidence of Cerebral Palsy (CP) is around 1 in 400 births. Approximately 1,800 children are diagnosed with CP every year. Just under half of children with cerebral palsy are born premature and the incidence increases in early premature deliveries of < 30 weeks gestation. The available evidence suggests that MgSO4 given before anticipated early preterm birth reduces the risk of cerebral palsy by 32%.
Objectives
| To assess the percentage of all eligible women receiving Magnesium Sulfate for fetal neuroprotection (as per National Neonatal audit programme - NNAP) To increase awareness of neuroprotective effects of Magnesium Sulphate among doctors and midwifes. |
Methods
Data was collected from Electronic Patient Record Systems; Badgernet and Euroking and all discrepant data was tallied with maternal notes. In the first part of audit 6 months data was collected and recommendations were made. A poster was made and displayed on the neonatal unit, and delivery suite, and this was used in addition to the education tools being used by the PReCEPT initiative.
Results
| After intervention we successfully surpassed the national standard that 85% of eligible mothers should receive Magnesium Sulfate. Our data shows that after intervention the percentage of eligible women receiving Magnesium Sulfate increased from 72% to 90%. |
Conclusion
| After intervention we successfully surpassed the national standard that 85% of eligible mothers should receive Magnesium Sulfate. Our data shows that after intervention the percentage of eligible women receiving Magnesium Sulfate increased from 72% to 90%. |